Literature DB >> 17980148

Production and characterization of a monoclonal antibody against GPR40 (FFAR1; free fatty acid receptor 1).

Akira Hirasawa1, Chisato Itsubo, Keiko Sadakane, Takafumi Hara, Shingo Shinagawa, Hanako Koga, Hiroshi Nose, Taka-aki Koshimizu, Gozoh Tsujimoto.   

Abstract

GPR40 is G protein-coupled receptor whose endogenous ligands have recently been identified as free fatty acids (FFAs), and it has been implicated to play an important role in FFA-mediated enhancement of glucose-stimulated insulin release. We have developed a monoclonal antibody against the extracellular domain of GPR40. Specificity of the antibody was demonstrated by immunoprecipitation and cell surface staining using GPR40-transfected cells. GPR40 immunoreactivity was highly abundant in mouse pancreatic beta-cells and splenocytes, THP-1 cells, and human peripheral blood mononuclear cells. The anti-GPR40 monoclonal antibody should prove valuable for further studying the function of this nutrient sensing receptor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17980148     DOI: 10.1016/j.bbrc.2007.10.142

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  G protein-coupled receptors as targets for anti-diabetic therapeutics.

Authors:  Da Young Oh; Jerrold M Olefsky
Journal:  Nat Rev Drug Discov       Date:  2016-01-29       Impact factor: 84.694

2.  Distribution and regulation of protein expression of the free fatty acid receptor GPR120.

Authors:  Satoshi Miyauchi; Akira Hirasawa; Tomoyo Iga; Ning Liu; Chisato Itsubo; Keiko Sadakane; Takafumi Hara; Gozoh Tsujimoto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-01-15       Impact factor: 3.000

3.  Evidence for involvement of uncoupling proteins in cerebral mitochondrial oxidative phosphorylation deficiency of rats exposed to 5,000 m high altitude.

Authors:  Yu Xu; Yuliang Liu; Chen Xia; Pan Gao; Jun-Ze Liu
Journal:  Neurochem Res       Date:  2012-12-25       Impact factor: 3.996

4.  Novel selective ligands for free fatty acid receptors GPR120 and GPR40.

Authors:  Takafumi Hara; Akira Hirasawa; Qi Sun; Keiko Sadakane; Chisato Itsubo; Tomoyo Iga; Tetsuya Adachi; Taka-aki Koshimizu; Toshihiro Hashimoto; Yoshinori Asakawa; Gozoh Tsujimoto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-05-27       Impact factor: 3.000

Review 5.  G protein-coupled receptors for energy metabolites as new therapeutic targets.

Authors:  Clara C Blad; Cong Tang; Stefan Offermanns
Journal:  Nat Rev Drug Discov       Date:  2012-07-13       Impact factor: 84.694

Review 6.  Metabolite-Sensing G Protein-Coupled Receptors Connect the Diet-Microbiota-Metabolites Axis to Inflammatory Bowel Disease.

Authors:  Hassan Melhem; Berna Kaya; C Korcan Ayata; Petr Hruz; Jan Hendrik Niess
Journal:  Cells       Date:  2019-05-14       Impact factor: 6.600

7.  Size- and Surface- Dual Engineered Small Polyplexes for Efficiently Targeting Delivery of siRNA.

Authors:  Shuang Liu; Shaohui Deng; Xiaoxia Li; Du Cheng
Journal:  Molecules       Date:  2021-05-27       Impact factor: 4.411

Review 8.  Treatment of type 2 diabetes by free Fatty Acid receptor agonists.

Authors:  Kenneth R Watterson; Brian D Hudson; Trond Ulven; Graeme Milligan
Journal:  Front Endocrinol (Lausanne)       Date:  2014-08-28       Impact factor: 5.555

Review 9.  The G-Protein-Coupled Long-Chain Fatty Acid Receptor GPR40 and Glucose Metabolism.

Authors:  Tsutomu Tomita; Kiminori Hosoda; Junji Fujikura; Nobuya Inagaki; Kazuwa Nakao
Journal:  Front Endocrinol (Lausanne)       Date:  2014-09-26       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.